The Board of Alere, Inc, a leading medical diagnostic firm, is evaluating the offer made by Ron Zwanziger, the firm's founder and former CEO, to acquire the company and take it private. The offer arrives at the end of a tumultuous year for the company, which saw Zwanziger fighting and ultimately losing a confrontation with activist investors Coppersmith Capital. How should the board evaluate this offer? Should they reject it, on the basis that Zwanziger's decision to expand into integrated healthcare solutions was the main reason behind the company's poor stock performance, as Coppersmith claimed? Or should they once more place their trust in Zwanziger's leadership, and in Alere's ability to effectively implement his vision?

【書誌情報】

ページ数：28ページ

サイズ：A4

商品番号：HBSP-717402

発行日：2016/8/30

登録日：2016/10/27